150 related articles for article (PubMed ID: 23726846)
1. Immune modulation by genetic modification of dendritic cells with lentiviral vectors.
Liechtenstein T; Perez-Janices N; Bricogne C; Lanna A; Dufait I; Goyvaerts C; Laranga R; Padella A; Arce F; Baratchian M; Ramirez N; Lopez N; Kochan G; Blanco-Luquin I; Guerrero-Setas D; Breckpot K; Escors D
Virus Res; 2013 Sep; 176(1-2):1-15. PubMed ID: 23726846
[TBL] [Abstract][Full Text] [Related]
2. Clinically feasible approaches to potentiating cancer cell-based immunotherapies.
Seledtsov VI; Goncharov AG; Seledtsova GV
Hum Vaccin Immunother; 2015; 11(4):851-69. PubMed ID: 25933181
[TBL] [Abstract][Full Text] [Related]
3. Toll-like receptor-mediated adjuvanticity and immunomodulation in dendritic cells: Implications for peptide vaccines.
Mitchell D; Yong M; Raju J; Willemsen N; Black M; Trent A; Tirrell M; Olive C
Hum Vaccin; 2011; 7 Suppl():85-93. PubMed ID: 21245658
[TBL] [Abstract][Full Text] [Related]
4. Chimeric antigen receptor engineering: a right step in the evolution of adoptive cellular immunotherapy.
Figueroa JA; Reidy A; Mirandola L; Trotter K; Suvorava N; Figueroa A; Konala V; Aulakh A; Littlefield L; Grizzi F; Rahman RL; Jenkins MR; Musgrove B; Radhi S; D'Cunha N; D'Cunha LN; Hermonat PL; Cobos E; Chiriva-Internati M
Int Rev Immunol; 2015 Mar; 34(2):154-87. PubMed ID: 25901860
[TBL] [Abstract][Full Text] [Related]
5. From pathogen to medicine: HIV-1-derived lentiviral vectors as vehicles for dendritic cell based cancer immunotherapy.
Dullaers M; Thielemans K
J Gene Med; 2006 Jan; 8(1):3-17. PubMed ID: 16288497
[TBL] [Abstract][Full Text] [Related]
6. Regulation of Toll-like receptor-induced chemokine production in murine dendritic cells by mitogen-activated protein kinases.
Mitchell D; Olive C
Mol Immunol; 2010 Jul; 47(11-12):2065-73. PubMed ID: 20451253
[TBL] [Abstract][Full Text] [Related]
7. Anti-melanoma vaccines engineered to simultaneously modulate cytokine priming and silence PD-L1 characterized using
Liechtenstein T; Perez-Janices N; Blanco-Luquin I; Goyvaerts C; Schwarze J; Dufait I; Lanna A; Ridder M; Guerrero-Setas D; Breckpot K; Escors D
Oncoimmunology; 2014; 3(7):e945378. PubMed ID: 25954597
[TBL] [Abstract][Full Text] [Related]
8. Immunization with a lentiviral vector stimulates both CD4 and CD8 T cell responses to an ovalbumin transgene.
Rowe HM; Lopes L; Ikeda Y; Bailey R; Barde I; Zenke M; Chain BM; Collins MK
Mol Ther; 2006 Feb; 13(2):310-9. PubMed ID: 16275163
[TBL] [Abstract][Full Text] [Related]
9. Selective activation of intracellular signalling pathways in dendritic cells for cancer immunotherapy.
Arce F; Kochan G; Breckpot K; Stephenson H; Escors D
Anticancer Agents Med Chem; 2012 Jan; 12(1):29-39. PubMed ID: 21707504
[TBL] [Abstract][Full Text] [Related]
10. Dendritic type, accessory cells within the mammalian thymic microenvironment. Antigen presentation in the dendritic neuro-endocrine-immune cellular network.
Bodey B; Bodey B; Kaiser HE
In Vivo; 1997; 11(4):351-70. PubMed ID: 9292303
[TBL] [Abstract][Full Text] [Related]
11. Enhancement of natural killer activity and IFN-γ production in an IL-12-dependent manner by a Brassica rapa L.
Yamamoto K; Furuya K; Yamada K; Takahashi F; Hamajima C; Tanaka S
Biosci Biotechnol Biochem; 2018 Apr; 82(4):654-668. PubMed ID: 29207919
[TBL] [Abstract][Full Text] [Related]
12. GITR agonist enhances vaccination responses in lung cancer.
Zhu LX; Davoodi M; Srivastava MK; Kachroo P; Lee JM; St John M; Harris-White M; Huang M; Strieter RM; Dubinett S; Sharma S
Oncoimmunology; 2015 Apr; 4(4):e992237. PubMed ID: 26137407
[TBL] [Abstract][Full Text] [Related]
13. Viral vectors for dendritic cell-based immunotherapy.
Humrich J; Jenne L
Curr Top Microbiol Immunol; 2003; 276():241-59. PubMed ID: 12797451
[TBL] [Abstract][Full Text] [Related]
14. Application of PD-1 Blockade in Cancer Immunotherapy.
Wu X; Gu Z; Chen Y; Chen B; Chen W; Weng L; Liu X
Comput Struct Biotechnol J; 2019; 17():661-674. PubMed ID: 31205619
[TBL] [Abstract][Full Text] [Related]
15. High levels of transduction of human dendritic cells with optimized SIV vectors.
Mangeot PE; Duperrier K; Nègre D; Boson B; Rigal D; Cosset FL; Darlix JL
Mol Ther; 2002 Mar; 5(3):283-90. PubMed ID: 11863418
[TBL] [Abstract][Full Text] [Related]
16. Alteration of T cell immunity by lentiviral transduction of human monocyte-derived dendritic cells.
Chen X; He J; Chang LJ
Retrovirology; 2004 Nov; 1():37. PubMed ID: 15518595
[TBL] [Abstract][Full Text] [Related]
17. Lentivirally transduced dendritic cells as a tool for cancer immunotherapy.
Breckpot K; Dullaers M; Bonehill A; van Meirvenne S; Heirman C; de Greef C; van der Bruggen P; Thielemans K
J Gene Med; 2003 Aug; 5(8):654-67. PubMed ID: 12898635
[TBL] [Abstract][Full Text] [Related]
18. Enhanced suppression of polyclonal CD8
Mu C; Zhang X; Wang L; Xu A; Ahmed KA; Pang X; Chibbar R; Freywald A; Huang J; Zhu Y; Xiang J
J Leukoc Biol; 2017 May; 101(5):1221-1231. PubMed ID: 28096300
[TBL] [Abstract][Full Text] [Related]
19. PPAR-γ agonist pioglitazone regulates dendritic cells immunogenicity mediated by DC-SIGN via the MAPK and NF-κB pathways.
Zhu W; Yan H; Li S; Nie W; Fan F; Zhu J
Int Immunopharmacol; 2016 Dec; 41():24-34. PubMed ID: 27792919
[TBL] [Abstract][Full Text] [Related]
20. Breast cancer vaccines delivered by dendritic cell-targeted lentivectors induce potent antitumor immune responses and protect mice from mammary tumor growth.
Bryson PD; Han X; Truong N; Wang P
Vaccine; 2017 Oct; 35(43):5842-5849. PubMed ID: 28916248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
